XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests
 9 Months Ended
Jan. 31, 2023
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests  
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests
The following table presents a summary of changes to the liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests:
Stock
Appreciation
Rights		Deferred
Compensation		Redeemable
Noncontrolling
Interests
(in thousands)
Balance as of April 30, 2022$30,878 $2,205 $11,026 
Amounts redeemed(5,627)——
Change in fair value5,887 200 1,003 
Balance as of January 31, 2023$31,138 $2,405 $12,029 
Classified as current as of April 30, 2022$1,532 $— $— 
Classified as long-term as of April 30, 202229,346 2,205 11,026 
Classified as current as of January 31, 2023$5,611 $541 $2,707 
Classified as long-term as of January 31, 202325,527 1,864 9,322 
Total expense related to these instruments was $7.1 million and $4.2 million during the nine months ended January 31, 2023 and 2022, respectively, and was included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income. Current and long-term liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests are included in other accrued expenses and liabilities and other liabilities, respectively, in the Condensed Consolidated Balance Sheets. See Note 13, "Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests," in the Company's Annual Report on Form 10-K for the year ended April 30, 2022 for more information regarding stock appreciation rights, deferred compensation and redeemable noncontrolling interests.